Health News sCD14

FDA Grants Approval for Heart Attack Trial

The US Food and Drug Administration has issued a “Study May Proceed” letter approving the commencement of clinical study with IC14 in patients with the most severe form of heart attack. An ST-elevated myocardial infarction (STEMI) is a very serious type of heart attack during which one of the heart’s major arteries supplying oxygen and […]

Press Research sCD14

New research links IC14 target to dementia

New research published in the world’s leading journal Neurology reports a link between higher levels of an inflammatory marker called sCD14 and a higher risk of developing dementia.  The study looked at blood samples and dementia diagnosis of more than 4,700 people over a decade. Researchers found that people with higher blood levels of sCD14 […]